Advertisement
Mayo Clinic Proceedings Home
MCP Digital Health Home
Research Article| Volume 66, ISSUE 3, P300-304, March 1991

Stiff-Man Syndrome

      Stiff-man syndrome (Moersch-Woltman syndrome) is a rare disorder of motor function characterized by involuntary stiffness of axial muscles and superimposed painful muscle spasms, which are often induced by startle or emotional stimuli. The standard treatment has been benzodiazepines. An association has been reported between stiff-man syndrome and epilepsy, insulin-dependent diabetes, and a variety of organ-specific autoimmune disorders. Antibodies directed against glutamic acid decarboxylase and against pancreatic islet cells have been detected in the serum and cerebrospinal fluid of patients with stiff-man syndrome. These findings suggest that stiff-man syndrome may be an autoimmune disease. Preliminary reports indicate that patients with stiff-man syndrome have a favorable response to plasma exchange and corticosteroid therapy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Moersch FP
        • Woltman HW
        Progressive fluctuating muscular rigidity and spasm (“stiff-man” syndrome): report of a case and some observations in 13 other cases.
        Proc Staff Meet Mayo Clin. 1956; 31: 421-427
        • Lorish TR
        • Thorsteinsson G
        • Howard Jr, FM
        Stiff-man syndrome updated.
        Mayo Clin Proc. 1989; 64: 629-636
        • Howard Jr, FM
        A new and effective drug in the treatment of the stiff-man syndrome: preliminary report.
        Mayo Clin Proc. 1963; 38: 203-212
        • Solimena M
        • Folli F
        • Denis-Donini S
        • Comi GC
        • Pozza G
        • De Camilli P
        • Vicari AM
        Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus.
        N Engl J Med. 1988; 318: 1012-1020
        • Speed JK
        • McEvoy KM
        • Lennon VA
        Anti-islet cell cytoplasmic antibodies: a serological marker of stiff-man syndrome (abstract).
        Program Abstr Annu Meet Endocr Soc. 1990; 72: 163
        • Solimena M
        • Folli F
        • Aparisi R
        • Pozza G
        • De Camilli P
        Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome.
        N Engl J Med. 1990; 322: 1555-1560
        • Vicari AM
        • Folli F
        • Pozza G
        • Comi GC
        • Comola M
        • Canal N
        • Besana C
        • Borri A
        • Tresoldi M
        • Solimena M
        • DeCamilli P
        Plasmapheresis in the treatment of stiff-man syndrome (letter to the editor).
        N Engl J Med. 1989; 320: 1499
        • Gordon EE
        • Januszko DM
        • Kaufman L
        A critical survey of stiff-man syndrome.
        Am J Med. 1967; 42: 582-599
        • Mackay IR
        Cirrhosis and other diseases of the liver.
        in: Samter M Immunological Diseases. Second edition. Little, Brown and Company, Boston1971: 1323-1345